Related Experiment Video
Updated: Jun 16, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
StrokeNet Thrombectomy Endovascular Platform (STEP): A Catalyst for Stroke Research
Chaitanya B Medicherla1, Amr Salem1, Vikalpa Dammavalam1
1From the Department of Neurology, New York Medical College, Westchester Medical Center, Valhalla, NY.
Endovascular thrombectomy is a critical treatment for acute ischemic stroke. Challenges remain in extending treatment windows, refining patient selection, optimizing posttreatment interventions, and expanding endovascular thrombectomy indications. Traditional stroke trials have played a pivotal role in advancing care but are hindered by inefficiencies, rigid designs, high costs, long timelines, and slow enrollment. The StrokeNet Thrombectomy Endovascular Platform (STEP) represents an innovative paradigm shift in stroke research, offering a more agile, cost-effective, and flexible trial design. Here, we explore the architecture of STEP and its implications on stroke research.
Endovascular thrombectomy is a critical treatment for acute ischemic stroke. Challenges remain in extending treatment windows, refining patient selection, optimizing posttreatment interventions, and expanding endovascular thrombectomy indications. Traditional stroke trials have played a pivotal role in advancing care but are hindered by inefficiencies, rigid designs, high costs, long timelines, and slow enrollment. The StrokeNet Thrombectomy Endovascular Platform (STEP) represents an innovative paradigm shift in stroke research, offering a more agile, cost-effective, and flexible trial design. Here, we explore the architecture of STEP and its implications on stroke research.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Venous Thrombosis III: Interprofessional Care

